Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Chipotle Mexican Grill
CMG
$41.5B
| $765M | 0.11% |
58,465,550
-13,864,250
| -19% | -$219M |
|
177
GoDaddy
GDDY
$11.5B
| $760M | 0.11% |
13,310,735
+5,693,990
| +75% | +$377M |
|
178
Applied Materials
AMAT
$428B
| $755M | 0.1% |
16,475,768
-2,969,510
| -15% | -$171M |
|
179
Equity Lifestyle Properties
ELS
$12.6B
| $752M | 0.1% |
13,083,923
-3,257,567
| -20% | -$222M |
|
180
Amdocs
DOX
$6.22B
| $751M | 0.1% |
13,666,876
-2,304,610
| -14% | -$154M |
|
181
Moderna
MRNA
$23.6B
| $742M | 0.1% |
24,759,391
+8,724,935
| +54% | +$201M |
|
182
Broadcom
AVGO
$2.04T
| $737M | 0.1% |
31,094,470
-5,467,730
| -15% | -$154M |
|
183
GSK
GSK
$106B
| $737M | 0.1% |
15,565,714
+165,654
| +1% | +$8.84M |
|
184
M&T Bank
MTB
$36.2B
| $737M | 0.1% |
7,121,435
+895,785
| +14% | +$132M |
|
185
Knight Transportation
KNX
$11.4B
| $732M | 0.1% |
22,322,700
-3,273,937
| -13% | -$116M |
|
186
Air Products & Chemicals
APD
$67.6B
| $729M | 0.1% |
3,651,734
+134,717
| +4% | +$30.7M |
|
187
Sarepta Therapeutics
SRPT
$1.77B
| $725M | 0.1% |
7,414,794
-762,451
| -9% | -$87.2M |
|
188
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $720M | 0.1% |
17,794,424
-4,838,596
| -21% | -$238M |
|
|
XLRN
189
DELISTED
Acceleron Pharma
XLRN
| $719M | 0.1% |
8,000,072
+37,837
| +0.5% | +$2.94M |
|
190
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $717M | 0.1% |
21,506,836
+18,516,758
| +619% | +$743M |
|
|
ONC
191
BeOne Medicines Ltd
ONC
$39.4B
| $704M | 0.1% |
5,717,920
+313,592
| +6% | +$49M |
|
192
Boeing
BA
$185B
| $702M | 0.1% |
4,705,891
-756,093
| -14% | -$207M |
|
193
Southern Company
SO
$107B
| $702M | 0.1% |
12,957,544
-2,154,623
| -14% | -$136M |
|
194
Northern Trust
NTRS
$33.9B
| $696M | 0.1% |
9,222,433
+705,192
| +8% | +$64.7M |
|
195
Sempra
SRE
$54.8B
| $695M | 0.1% |
12,307,998
-1,167,948
| -9% | -$82.9M |
|
|
196
Stryker
SYK
$130B
| $693M | 0.1% |
4,163,725
-6,711,256
| -62% | -$1.31B |
|
|
COUP
197
DELISTED
Coupa Software Incorporated
COUP
| $693M | 0.1% |
4,959,943
+1,020,939
| +26% | +$158M |
|
198
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
| $692M | 0.1% |
8,543,248
+997,935
| +13% | +$95.3M |
|
199
Biogen
BIIB
$30.7B
| $692M | 0.1% |
2,187,836
+729,227
| +50% | +$221M |
|
|
INFO
200
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $692M | 0.1% |
11,527,772
-1,040,467
| -8% | -$74.9M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.